Britain offers all over-50s first Covid shots, Moderna rollout begins

Britain has offered shots to high-priority groups; PM Boris Johnson aims to offer all adults a shot by July-end

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Representational image
Reuters
3 min read Last Updated : Apr 13 2021 | 3:15 PM IST
Britain has offered all over-50s a first dose of COVID-19 vaccine and launched the Moderna shot in England, the government said on Tuesday, putting it on track to give a shot to all adults by the end of July.
 
Britain has seen one of the world's quickest vaccine rollouts, behind only Israel in the proportion of its population receiving at least one dose of a COVID-19 shot.
 
The government said it had now offered at least one shot to priority cohorts 1 to 9, which include all adults over 50, the clinically vulnerable, and health and social care workers, ahead of a target to do so by Thursday.
 
"We will now move forward with completing essential second doses and making progress towards our target of offering all adults a vaccine by the end of July," Prime Minister Boris Johnson said in a statement.
 
Britain has slowed down the pace of first doses, to ensure people in high-priority groups receive a second dose despite lower vaccine supplies in April than March.
 
In a boost to vaccine supplies for first doses, the rollout of Moderna's shot in England begins on Tuesday, after first doses were given in Wales last week.
 
Already used in the United States and other parts of Europe, it becomes the third vaccine to be used in Britain after AstraZeneca and one from Pfizer-BioNTech.
 
Moderna uses the same mRNA technology as Pfizer's shots but can be stored at normal fridge temperatures unlike its rival U.S. vaccine, which must be kept and shipped at ultra-low temperatures.
 
Johnson's office said that the government remained on track to offer all adults a shot by July 31. On Tuesday, the National Health Service said that people aged 45 or over could now book appointments to receive a COVID-19 vaccine.
 
The success of the vaccine programme has underpinned Johnson's roadmap out of lockdown, which on Monday saw all shops and outdoor hospitality settings in England reopen, with some celebrating on the street into the evening.
 
Adding a note of caution to the optimism, the government announced an expansion of so-called surge testing in the south London boroughs of Lambeth and Wandsworth to detect cases of the variant first found in South Africa.
 
There have been 74 confirmed and probable cases of the coronavirus variant, known as B.1.351, in the boroughs, and there is concern that vaccines are less effective against it.
 
"The important thing will be to watch: If the South African variant has really taken off, and we'll probably know in about two to three weeks, then we may need to pause re-opening a little bit," James Naismith, professor of structural biology at the University of Oxford and director of Rosalind Franklin Institute, told BBC Radio.
 
With more than 127,000 fatalities, the United Kingdom has the fifth-highest death toll in the world from COVID-19.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusBritainCoronavirus VaccineCoronavirus Tests

Next Story